Determinant | Outcome | Unadjusted OR (95% CI) | Fully adjusted OR (95% CI) |
---|---|---|---|
Top-up price | PWV | 1.15 (1.02-1.29) | 0.65 (0.45-0.94) |
IV | 0.73 (0.62-0.86) | 0.94 (0.58-1.53) | |
Retailer-clinic ratio | PWV | 1.01 (0.89-1.15) | 1.43 (1.31-1.57) |
IV | 0.82 (0.70-0.96) | 1.27 (1.17-1.40) | |
Universal coverage campaign | PWV | 1.11 (0.90-1.40) | 1.55 (1.06-2.27) |
IV | 2.06 (1.69-2.53) | 1.26 (0.88-1.80) | |
Under-five coverage campaign | PWV | 0.70 (0.60-0.82) | 1.18 (0.92-1.54) |
IV | 1.76 (1.42-2.20) | 1.44 (1.03-2.01) | |
Malaria prevalence | PWV | 1.01 (0.99-1.02) | 1.01 (0.99-1.01) |
IV | 0.99 (0.98-1.01) | 1.01 (0.99-1.03) | |
Socio-economic status | PWV | 1.33 (1.02-1.70) | 1.35 (1.02-1.73) |
IV | 1.39 (1.12-1.72) | 1.43 (1.10-1.70) | |
Exposure of men to mass media | PWV | 1.25 (0.92-1.70) | 0.99 (0.98-1.01) |
IV | 1.21 (0.87-1.69) | 1.01 (0.99-1.01) | |
Exposure of women to mass media | PWV | 1.19 (0.94-1.51) | 1.01 (0.99-1.01) |
IV | 1.17 (0.90-1.53) | 1.00 (0.99-1.01) |